The store will not work correctly when cookies are disabled.
1-(tert-butylamino)-3-(5,8-dihydronaphthalen-1-yloxy)propan-2-ol
ID: ALA3246767
PubChem CID: 11087015
Max Phase: Preclinical
Molecular Formula: C17H25NO2
Molecular Weight: 275.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)NCC(O)COc1cccc2c1CC=CC2
Standard InChI: InChI=1S/C17H25NO2/c1-17(2,3)18-11-14(19)12-20-16-10-6-8-13-7-4-5-9-15(13)16/h4-6,8,10,14,18-19H,7,9,11-12H2,1-3H3
Standard InChI Key: JDOKKQREDFLVNP-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
13.5851 -10.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2961 -10.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3000 -11.7447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5950 -12.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8860 -11.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1810 -12.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4699 -11.7642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4640 -10.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1690 -10.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8800 -10.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5791 -9.7063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2838 -9.2925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9945 -9.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6992 -9.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0005 -10.5131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4099 -9.6856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1146 -9.2718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8252 -9.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1086 -8.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8172 -8.8570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
1 10 2 0
5 10 1 0
1 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 19 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 275.39 | Molecular Weight (Monoisotopic): 275.1885 | AlogP: 2.47 | #Rotatable Bonds: 5 |
Polar Surface Area: 41.49 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.76 | CX LogP: 2.97 | CX LogD: 0.66 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.81 | Np Likeness Score: -0.03 |
References
1. Condon ME, Cimarusti CM, Fox R, Narayanan VL, Reid J, Sundeen JE, Hauck FP.. (1978) Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols., 21 (9): [PMID:31485] [10.1021/jm00207a014] |